Netherlands· NL-74ff303f9e35
Diclofenac Devatis 1 mg/ml, oogdruppels, oplossing, verpakking voor éénmalig gebruik
A diclofenac product containing diclofenac natrium, registered in Netherlands by Devatis GmbH. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Diclofenac is registered in 13 of 19 countries.
Countries holding a registration under ATC S01BC03 (diclofenac), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Diclofenac · ATC S01BC03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DICLOFENAC NATRIUM
- Manufacturer
- Devatis GmbH
- Country
- Netherlands (NL)
- ATC code
- S01BC03
- ATC class
- Diclofenac
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id113364
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
90 interactions on record for diclofenac.
Graded by severity as the source publishes them — 89 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diclofenac · interactions on record
90 records
- 89 moderate
- 1 minor
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Antithrombin IIIB01AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Diclofenac in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayDiclo-Vision sineOmniVision
- SwedenDicloabak 1 mg/ml Ögondroppar, lösning2care4 ApS
- FinlandDicloabakOrifarm Oy
- United StatesDiclofenacAltaire Pharmaceuticals Inc.
- PolandDicloabakLaboratoires Thea
- FranceVOLTARENOPHTA 0,1 POUR CENT (0,3 mg/0,3 ml), collyre en solution en récipient unidoseTHEA
- BelgiumDicloabak 1 mg/ml 0.1 %Laboratoires Théa
- CzechiaDICLOABAKLaboratoires Thea, Clermont-Ferrand
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Dedolor Akut, Dedolor Drs
- Belgium · Cataflam, Dicloabak
- Bulgaria · Diclofenac-Tchaikapharma, Алмирал
- Cyprus · Almiral, Areston
- Czechia · Almiral, Dicloabak
- Germany · Arthrex Schmerzgel, Diclac
- Denmark · Diclodan, Diclofenac Bluefish
- Estonia · Almiral, Dagesil
- Spain · Cinfadol, Dagesil
- Finland · Dicloabak, Diclomex Rapid
- France · Antalcalm, Diclamine
- United Kingdom (Northern Ireland) · Akis, Amgesic Muscle & Back Pain Relief
- Greece · Batafil, Denaclof
- Croatia · Diclac Duo, Diclo Duo
- Hungary · Algoplast, Cataflam
- Ireland · Cataflam, Diclac
- Iceland · Diclofenac Alvogen, Dimax
- Italy · Brexiadvance, Dealgic
- Lithuania · Dagesil, Diclac
- Luxembourg · Cataflam, Dicloabak
- Latvia · Almiral, Dagesil
- Malta · Almiral, Areston
- Norway · Cataflam, Diclofenac Bluefish
- Poland · Adarostin, Akis
- Portugal · Dagesil, Dicipan
- Romania · Almiral, Clafen
- Sweden · Dicloabak, Diclofenac Bluefish
- Slovenia · Diclo Duo, Dicloflex
- Slovakia · Akis Plus, Almiral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec50d6ec-77cc-4692-8d15-1d9b2e1c9c6d GET /v1/drugs/ec50d6ec-77cc-4692-8d15-1d9b2e1c9c6d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h113364_smpc.pdf",
"strength": null,
"atc_label": "Diclofenac",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg113364",
"excipients": [
"BOORZUUR (E 284)",
"MACROGOLGLYCEROLRICINOLEAAT",
"TROMETAMOL",
"WATER, GEZUIVERD"
],
"substances": [
"DICLOFENAC NATRIUM"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h113364.pdf",
"authorised_at": "2014/12/16",
"procedure_number": "NL/H/2859/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "113364",
"additional_monitoring": "N"
}See everything about diclofenac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.